Neelima Denduluri
7PUBLICATIONS
69CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Sep 12, 2024
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01.Aditya Bardia, Komal Jhaveri, Seock-Ah Im
|May 10, 2024
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.Filipa Lynce, Candace Mainor, Renee N Donahue
|Mar 28, 2024
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.Filipa Lynce, Candace Mainor, Renee N Donahue
|May 18, 2021
Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0.Sara M Tolaney, Elizabeth Garrett-Mayer, Julia White
|Jan 28, 2021
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.Larissa A Korde, Mark R Somerfield, Lisa A Carey
|Dec 21, 2019
Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study.Jeanne S Mandelblatt, Wanting Zhai, Jaeil Ahn
Pageof 2
Frequent Collaborators
3 joint publications
Sara M Tolaney
2 joint publications
George Luta
2 joint publications
Martine Extermann
2 joint publications
Jeanne S Mandelblatt
2 joint publications
Renee N Donahue
2 joint publications
Ilana Schlam
2 joint publications
Candace Mainor
2 joint publications
Greg Jones
2 joint publications
Xue Geng
2 joint publications
Filipa Lynce
